Related Experiment Video

Updated: May 25, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Ligand-binding assays in the 21st Century laboratory: recommendations for an automated data interchange process

Sheldon S Leung1, Joel Usansky, Robert Lynde

  • 1Pfizer Inc., Andover, Massachusetts, 01810, USA. sheldon.leung@pfizer.com

The AAPS Journal
|January 17, 2012
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay
07:52

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay

Published on: September 10, 2018

Bio-layer Interferometry for Measuring Kinetics of Protein-protein Interactions and Allosteric Ligand Effects
13:57

Bio-layer Interferometry for Measuring Kinetics of Protein-protein Interactions and Allosteric Ligand Effects

Published on: February 18, 2014

Related Experiment Videos

Last Updated: May 25, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay
07:52

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay

Published on: September 10, 2018

Bio-layer Interferometry for Measuring Kinetics of Protein-protein Interactions and Allosteric Ligand Effects
13:57

Bio-layer Interferometry for Measuring Kinetics of Protein-protein Interactions and Allosteric Ligand Effects

Published on: February 18, 2014

Related Concept Videos

The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...

Articles linked to this work by shared authors, journal, and citation graph.

2025 White Paper on Recent Issues in Bioanalysis: Redosing Patients with AAV Gene Therapy; CRS Immunogenicity Risk; Shedding Assays; NHP Studies Immunogenicity; CMC vs Bioanalytical Assays; Artificial Intelligence-Powered Genomic Pipelines for NGS (PART 3A - Recommendations on Gene, Cell, and Vaccine Therapies Immunogenicity & Technologies; Biotherapeutics & Biosimilars Immunogenicity Assessment & Clinical Relevance PART 3B - Regulatory Agencies' Input on Immunogenicity/Technologies of Biotherapeutics, Gene, Cell & Vaccine Therapies).

Bioanalysis·2026

Addressing Clinical Challenges in Aberrant Pharmacokinetics of Biologic Therapeutic Drugs: Investigating Sample Processing Procedure in the Immunoassays.

The AAPS journal·2025

Implementation of a Three-Way Comparability Assessment for a Bioanalytical Anti-Drug Antibody Method.

The AAPS journal·2024

Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells.

Nature·2024

Pharmacokinetics (PK) of Tiragolumab in First-in-Human Study in Patients with Mixed Solid Tumors (GO30103).

Journal of clinical pharmacology·2023

Cloud security in a bioanalytical world: considerations for use of third-party cloud services for bioanalysis.

Bioanalysis·2023

Industry Perspective on Translational and Clinical Pharmacology Aspects of Viral-based Gene Therapies and Vaccines-Key Considerations and Learnings From Approved Products.

The AAPS journal·2026

A Machine Learning Platform for Imputing Missing Critical Quality Attributes in Pharmaceutical Development.

The AAPS journal·2026

Design, Optimization and Evaluation of Taste-Masked Acemetacin Formulations Using Purolite A430MR.

The AAPS journal·2026

An In Vitro Quantitative Systems Pharmacology Platform for Characterizing CD3-Bispecific Antibody-Mediated T-Cell Activation and Tumor Cell Cytotoxicity.

The AAPS journal·2026

Assessment of Sorbitol as a Pharmaceutical Excipient in Oral Liquid Pediatric Formulations Submitted to the U.S. FDA.

The AAPS journal·2026

Calculating Receptor Occupancy using TMDD Models - What has to be Considered?

The AAPS journal·2026

Assessment of AI-based cephalometric landmark recognition on lateral cephalometric radiographs.

Frontiers in oral health·2026

A large language models-assisted and expert-corrected workflow for preoperative anesthesia assessment drafts: A single-centre exploratory feasibility study.

Medicina clinica·2026

Enhanced Semantic Alignment in Transformer Tracking via Position Learning and Force-Directed Attention.

IEEE transactions on pattern analysis and machine intelligence·2026

Advanced Automatic Crash Notification Systems: It Is Time to Adopt Potentially Life-Saving Technology.

Journal of the American College of Surgeons·2026

Letter to the Editor: Artificial intelligence in nephrology point-of-care ultrasonography - opportunities, limitations, and future directions.

World journal of nephrology·2026

PFEA: a VLM-based high-level natural language planning and feedback embodied agent for human-centered AI.

Frontiers in robotics and AI·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us